Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Chan KH et al. |
Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model. |
1988 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:2844210
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Retsema J et al. |
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2449865
|
Girard AE et al. |
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2830841
|
Walsh M et al. |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:3038010
|
Poizeau F et al. |
[Shifting cellulitis in a patient with X-linked hypogammaglobulinemia]. |
|
Ann Dermatol Venereol |
pmid:27080822
|
Seguà DÃaz M |
[What is the best treatment for urogenital Chlamydia trachomatis infection?] |
|
Semergen |
pmid:27068255
|
Sharma P et al. |
Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade. |
|
Indian J Med Microbiol |
pmid:29735830
|
Singh M et al. |
Sunray appearance in lacrimal canaliculitis. |
|
Indian J Pathol Microbiol |
pmid:29676385
|